Qualigen Therapeutics Inc Capital Reinvestment Ratio
Qualigen Therapeutics Inc capital reinvestment ratio. Qualigen Therapeutics Inc (QLGN) has a Capital Reinvestment Ratio of 0.27x as of September 2023, meaning it reinvests 0% of its operating cash flow ($929.74K) in capital expenditures ($246.42K). Check QLGN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Qualigen Therapeutics Inc (2019–2019)
Capital reinvestment ratio of Qualigen Therapeutics Inc from 2019 to 2019. This chart tracks Qualigen Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Qualigen Therapeutics Inc (QLGN) net asset momentum to track the company's year-over-year net asset growth rate.
Qualigen Therapeutics Inc Capital Reinvestment Ratio by Year (2019–2019)
Qualigen Therapeutics Inc capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see how efficiently does Qualigen Therapeutics Inc generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 3.39x | $57.33K | $194.48K | — |